Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells
Status:
Terminated
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
Patients with hematologic malignancies will receive myeloablative chemotherapy followed by
stem cell rescue with bone marrow or hematopoietic peripheral blood stem cells collected by
apheresis from a filgrastim- (G-CSF)-mobilized haploidentical related-donor, ie,
hematopoietic peripheral blood stem cell transplant (HSCT).